Treatment of chorea
Reading Document
Medical Text Search
treatment of chorea pharmacological management
Medical Text Search
Huntington disease chorea Sydenham chorea therapy
GradeResponse
GradeResponse
Treatment of Chorea
Chorea is managed based on its underlying etiology, but several pharmacological principles apply broadly. Below is a structured overview.
General Principles
Chorea is an involuntary, irregular, non-rhythmic movement disorder. Treatment targets both the underlying cause and symptomatic control of the movements.
1. Huntington's Disease (HD) Chorea
(Harrison's Principles of Internal Medicine, 21st Ed., p. 12373)
There is currently no disease-modifying therapy. Management is multidisciplinary (neurology, psychiatry, social work, genetic counseling).
Pharmacological Control of Chorea
| Drug | Mechanism | Notes |
|---|---|---|
| Tetrabenazine | Presynaptic dopamine depletion (VMAT2 inhibitor) | FDA-approved for HD chorea; risk of secondary parkinsonism, depression, sedation |
| Deutetrabenazine (Austedo) | VMAT2 inhibitor (deuterated form) | FDA-approved; longer half-life, better tolerability than tetrabenazine |
| Valbenazine | VMAT2 inhibitor | Approved for tardive dyskinesia; used off-label for HD chorea |
| Haloperidol / Fluphenazine | D2 receptor blockers | Effective for chorea; risk of tardive dyskinesia with long-term use |
| Olanzapine / Risperidone | Atypical antipsychotics | Dopamine-blocking; may control chorea with lower tardive dyskinesia risk |
| Amantadine | NMDA antagonist | Modest anti-choreic effect in some patients |
Non-motor Symptoms (HD)
- Depression/anxiety: SSRIs, mirtazapine
- Psychosis: quetiapine, olanzapine
- Irritability: SSRIs, valproate, atypical antipsychotics
- Cognitive decline: no proven pharmacotherapy
2. Sydenham's Chorea (Post-Streptococcal)
Treatment
- Antibiotic therapy: Penicillin (or amoxicillin) to eradicate group A streptococcus; secondary prophylaxis with monthly benzathine penicillin G to prevent recurrence
- Symptomatic chorea control (for moderate-severe cases):
- Valproic acid — first-line in many guidelines
- Carbamazepine — effective alternative
- Haloperidol — historically used but higher side-effect burden
- Corticosteroids (prednisolone) — may shorten duration in severe cases; evidence is limited
3. Drug-Induced Chorea
- Discontinue the offending agent (e.g., levodopa, antipsychotics causing tardive chorea, oral contraceptives, stimulants, phenytoin, lithium)
- If dopamine agonist-induced (e.g., levodopa dyskinesia in Parkinson's disease): reduce dose, add amantadine, or consider deep brain stimulation (STN/GPi)
- Tardive chorea: VMAT2 inhibitors (tetrabenazine, deutetrabenazine, valbenazine)
4. Metabolic / Systemic Causes
| Cause | Treatment |
|---|---|
| Thyrotoxicosis | Antithyroid therapy (chorea resolves with euthyroidism) |
| Polycythemia vera | Treat underlying disorder; low-dose aspirin |
| Hyperglycemic chorea (non-ketotic hyperosmolar) | Correct hyperglycemia; chorea typically resolves |
| SLE/antiphospholipid syndrome | Immunosuppression (steroids, hydroxychloroquine), anticoagulation |
| Wilson's disease | Penicillamine or trientine (copper chelation); zinc supplementation |
5. Genetic / Other Causes
- Neuroacanthocytosis: symptomatic — VMAT2 inhibitors, antipsychotics; no disease-modifying therapy
- Benign hereditary chorea (NKX2.1 mutations): often mild; tetrabenazine if functionally disabling
- Chorea gravidarum: withdraw causative agents; dopamine blockers if severe; resolves post-partum
Key Takeaways
- VMAT2 inhibitors (tetrabenazine, deutetrabenazine) are the most evidence-backed agents for symptomatic chorea regardless of etiology.
- Dopamine-blocking agents (haloperidol, olanzapine) are effective alternatives but carry long-term risks.
- Treat the cause whenever possible — metabolic and autoimmune choreas are often reversible.
- Multidisciplinary care (neurology, psychiatry, physiotherapy, genetic counseling) is essential in chronic conditions like HD.
This is a shared conversation. Sign in to Orris to start your own chat.